Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities.
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities. Ann Am Thorac Soc. 2019 05; 16(5):534-539.
View in:
PubMed
subject areas
Administration, Inhalation
Anti-Bacterial Agents
Cystic Fibrosis
Humans
Pseudomonas aeruginosa
Pseudomonas Infections
authors with profiles
Patrick A. Flume